Higher Dosage

  • Author: ChemistryViews
  • Published: 02 August 2010
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Massachusetts Institute of Technology/Proc. Natl. Acad. Sci
thumbnail image: Higher Dosage

Cisplatin, one of the first chemotherapy drugs, is good at killing cancer cells, but can also seriously damage kidneys.

Shiladitya Sengupta and team, Harvard-MIT Division of Health Sciences and Technology, USA, have found that encasing cisplatin in nanoparticles that are too large to enter the kidneys allows for higher doses to be prescribed.


The cisplatin was bound by a glucosamine-functionalized polyisobutylene-maleic acid polymer which self-assembles into a nanoparticle. The nanoparticle releases Pt in a pH-dependent manner and outperformed cisplatin in mice engineered to develop ovarian cancer.


The researchers are now working on new variants of the nanoparticles that would be easier to manufacture. They are planning to test the nanoparticles in clinical trials, which Sengupta hopes will get underway within the next two years.


Article Views: 1580

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH